Arrowhead Pharmaceuticals
ARWR
#2176
Rank
โ‚ฌ7.29 B
Marketcap
52,77ย โ‚ฌ
Share price
-4.98%
Change (1 day)
136.60%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): -โ‚ฌ59.1 Million

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.57 Billion. In 2024 the company made an earning of -โ‚ฌ0.52 Billion a decrease over its 2023 earnings that were of -โ‚ฌ0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ59.1 Million-88.54%
2024 -โ‚ฌ0.52 Billion112.45%
2023 -โ‚ฌ0.25 Billion87.79%
2022 -โ‚ฌ0.13 Billion-20.1%
2021 -โ‚ฌ0.17 Billion67.59%
2020 -โ‚ฌ96.51 Million-347.53%
2019 โ‚ฌ38.98 M-245.59%
2018 -โ‚ฌ26.78 Million-13.17%
2017 -โ‚ฌ30.85 Million-52.28%
2016 -โ‚ฌ64.64 Million-16.57%
2015 -โ‚ฌ77.48 Million30.32%
2014 -โ‚ฌ59.45 Million171.62%
2013 -โ‚ฌ21.89 Million16.56%
2012 -โ‚ฌ18.78 Million107.53%
2011 -โ‚ฌ9.05 Million
2008 -โ‚ฌ31.87 Million-8.07%
2007 -โ‚ฌ34.67 Million70.37%
2006 -โ‚ฌ20.35 Million122.51%
2005 -โ‚ฌ9.15 Million147.41%
2004 -โ‚ฌ3.7 Million2002.28%
2003 -โ‚ฌ0.18 Million-85.61%
2002 -โ‚ฌ1.23 Million1371.97%
2001 -โ‚ฌ0.09 Million-13.45%
2000 -โ‚ฌ0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alnylam Pharmaceuticals
ALNY
โ‚ฌ0.11 B-273.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ0.11 Billion 56.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ57.36 M-188.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-โ‚ฌ92.85 Million 43.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.82 B-43,253.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-โ‚ฌ2.71 Billion 4,089.31%๐Ÿ‡บ๐Ÿ‡ธ USA